Back to Search
JOSEPH JURCIC, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1295838076IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
185844(NY)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
185844(NY)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
185844(NY)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 1988
Research & Publications (20)
Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia.
PMID 11675334·Blood·2001
8-other
Antibody therapy for residual disease in acute myelogenous leukemia.
PMID 11255080·Crit Rev Oncol Hematol·2001
6-review
Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches.
PMID 10882181·Curr Opin Hematol·2000
6-review
Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia.
PMID 10690513·Clin Cancer Res·2000
3-trial
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
PMID 19557623·Leuk Lymphoma·2009
3-trial
Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
PMID 19282418·J Oncol Pharm Pract·2009
4-observational
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.
PMID 19075280·J Clin Oncol·2009
4-observational
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
PMID 16520464·J Clin Oncol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 622 W 168TH ST
NEW YORK, NY 10032 - Phone
- (646) 227-3275
Quick Facts
- NPI
- 1295838076
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile